Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease

Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease
Treatment has been completed in a Phase 2 clinical trial of brilacidin for ulcerative proctitis and ulcerative proctosigmoiditis — a study that led to six of the 12 patients’ bowel diseases going into remission. Innovation Pharmaceuticals will present the trial results at the Drug Discovery & Therapy World Congress in Boston on July 13. The two

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Terry Funk says:

    What happened to the phase 3 trial of Brilacidin for staph jnfections or ABBSi. I have information about a patient here in Bend Oregon who is going to die because they have used all of the last resort antibiotics to no effect. If a patient is going to die anyway what would it hurt to treat him with a drug like brilacidin. If it works you have a win win situation.

Leave a Comment

Your email address will not be published. Required fields are marked *